| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/20/2002 | CN1340347A Hypoglycemic life-elongating tablet and its preparing process |
| 03/20/2002 | CN1340312A Instant food for preventing and curing hyperlipomia and its preparing process |
| 03/20/2002 | CN1081184C Fluorinated vitamin D3 analogs |
| 03/20/2002 | CN1081046C Medicinal decoction for treating diabets and its preparing process |
| 03/20/2002 | CN1081038C Beta-glucan products and extraction process from cereals thereof |
| 03/20/2002 | CN1081032C Medicinal preparation containing saccharin zinc |
| 03/20/2002 | CN1081031C Calcium tablet |
| 03/20/2002 | CN1081015C Antilipemic beverage |
| 03/19/2002 | US6359017 Dietary compositions and methods |
| 03/19/2002 | US6359012 Method for making 24(S)-hydroxyvitamin D2 |
| 03/19/2002 | US6358999 Orally administering zinc tranexamate for diabetis therapy |
| 03/19/2002 | US6358998 Body fat-reducing agent comprising dioxabicyclo[3.3.0] octane derivative as active ingredient |
| 03/19/2002 | US6358991 By administering indole compounds such as 1-(4-(2-azepan-1yl-ethoxy)-benzyl)-2-(4-hydroxy-phenyl)-3-methyl-1h-indol-5 -ol; epilepsy, asthma, eating disorders, obesity, neurodegenertive conditions, schizophrenia |
| 03/19/2002 | US6358958 Arylpiperazines having activity at the serotonin 1A receptor |
| 03/19/2002 | US6358954 PDGF receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
| 03/19/2002 | US6358945 Compounds useful as anti-inflammatory agents |
| 03/19/2002 | US6358924 GLP-1 formulations |
| 03/19/2002 | US6358920 Nonapeptide anticarcinogenic and antimetastasis agents |
| 03/19/2002 | US6358522 For reducing anal leakage of oil in a patient to whom orlistat is being administered |
| 03/19/2002 | CA2236673C (-)cis-6(s)-phenyl-5(r)-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol d-tartrate |
| 03/19/2002 | CA2204384C Medicinal composition for diabetes |
| 03/19/2002 | CA2134560C Anti-obesity drugs |
| 03/19/2002 | CA2128078C Nutritional product for trauma and surgery patients |
| 03/19/2002 | CA2050331C Ureido derivatives of poly-4-amino-2-carboxy-1-methyl compounds |
| 03/18/2002 | CA2319928A1 Apoptosis-mimicking synthetic entities and use thereof in medical treatments |
| 03/15/2002 | CA2357155A1 Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production |
| 03/14/2002 | WO2002021141A2 Methods and compositions for diseases associated with amyloidosis |
| 03/14/2002 | WO2002020822A2 Biopanning and rapid analysis of selective interactive ligands (brasil) |
| 03/14/2002 | WO2002020807A1 L-methionine $g(g)-lyase with modified function |
| 03/14/2002 | WO2002020769A1 Human and mouse targeting peptides identified by phage display |
| 03/14/2002 | WO2002020736A2 Proteases |
| 03/14/2002 | WO2002020724A2 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 03/14/2002 | WO2002020723A2 Compositions and methods for targeting peptides in humans in vivo |
| 03/14/2002 | WO2002020722A2 Methods and compositions for in vitro targeting |
| 03/14/2002 | WO2002020619A2 HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE$m(3) |
| 03/14/2002 | WO2002020615A2 Antibody and/or chemokine constructs which bind to a chemokine receptor and their use in immunological disorders |
| 03/14/2002 | WO2002020530A1 Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors |
| 03/14/2002 | WO2002020525A2 Protein tyrosine phosphatase inhibitor |
| 03/14/2002 | WO2002020520A1 A thiazolidinedione derivative and its use as antidiabetic |
| 03/14/2002 | WO2002020519A1 The hydrochloride salt of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione |
| 03/14/2002 | WO2002020518A1 Thiazolidinone nitrate salt |
| 03/14/2002 | WO2002020517A1 A thiazolidinedione derivative and its use as antidiabetic |
| 03/14/2002 | WO2002020501A2 Polyarylcarboxamides useful as lipid lowering agents |
| 03/14/2002 | WO2002020495A2 Inhibitors of glycogen synthase kinase 3 |
| 03/14/2002 | WO2002020489A2 QUINOLINE INHIBITORS OF cGMP PHOSPHODIESTERASE |
| 03/14/2002 | WO2002020488A2 Quinoline and quinazoline derivatives as ligands for the neuropeptide y receptor |
| 03/14/2002 | WO2002020485A1 Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases |
| 03/14/2002 | WO2002020483A1 Piperidine derivatives for use 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 03/14/2002 | WO2002020465A2 Gamma-ketoacid dipeptides as inhibitors of caspase-3 |
| 03/14/2002 | WO2002020464A2 Benzene tricarboxylic acid amides as insulin receptor activators |
| 03/14/2002 | WO2002020457A1 Dihydroxy open-acid salt of simvastatin |
| 03/14/2002 | WO2002020040A1 Mimetic peptides for epitope of apolipoprotein b-100, concatemer and modified peptides thereof, and the vaccine composition comprising the same |
| 03/14/2002 | WO2002020021A1 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications |
| 03/14/2002 | WO2001090189A3 G-protein coupled receptor org3. |
| 03/14/2002 | WO2001083713A3 The use of tolerogenic dendritic cells for enhancing tolerogenicity in a host and methods for making the same |
| 03/14/2002 | WO2001072290A3 Method for the improvement of islet signaling in diabetes mellitus and for its prevention |
| 03/14/2002 | WO2001070757A3 Thioketals and thioethers for inhibiting the expression of vcam-1 |
| 03/14/2002 | WO2001070668B1 Amines substituted with a dihydronaphthalenyl, crhomenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| 03/14/2002 | WO2001066553A3 Novel aryl fructose-1,6-bisphosphatase inhibitors |
| 03/14/2002 | WO2001066081A3 Pharmaceutical preparations containing saccharose fatty acid esters for controlling the release of active ingredients |
| 03/14/2002 | WO2001064668A3 1,3-dihydro-2h-indol-2-one, and their use as v1b or both v1b and v1a arginine-vasopressin ligand receptors |
| 03/14/2002 | WO2001062737A3 Amino pyrazole derivatives useful for the treatment of obesity and other disorders |
| 03/14/2002 | WO2001061007A3 Fibroblast growth factor-23 molecules and uses thereof |
| 03/14/2002 | WO2001057085A3 G-protein coupled receptors |
| 03/14/2002 | WO2001057081A3 Narc-1, subtilase-like homologs |
| 03/14/2002 | WO2001055392A3 Nuclear hormone receptors |
| 03/14/2002 | WO2001055198A3 Dermo- and gastro-specific sphingolipid activator |
| 03/14/2002 | WO2001055134A3 Novel 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b and v1a arginine-vassopressin receptors |
| 03/14/2002 | WO2001055130A3 Novel 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b and v1a arginine-vasopressin receptors |
| 03/14/2002 | WO2001054659A3 Slimming cosmetic composition comprising a plant extract containing a plant natriuretic peptide (pnp) |
| 03/14/2002 | WO2001048162A3 Method for the production of vitamin a |
| 03/14/2002 | WO2001044497A3 Protein kinase regulation |
| 03/14/2002 | WO2001036684A3 Mammalian toxicological response markers |
| 03/14/2002 | WO2001032130A3 Phenyl amine carboxylic acid compounds and compositions for delivering active agents |
| 03/14/2002 | WO2001022982A3 Compositions for reducing sympathomimetic-induced side effects by serenoa repens extract |
| 03/14/2002 | WO2001020031A3 Polymorphisms in a klotho gene |
| 03/14/2002 | WO2000065028A9 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR |
| 03/14/2002 | WO2000058483A9 Protozoan expression system |
| 03/14/2002 | WO2000056899A9 Dsp-2 dual-specificity map kinase phosphatase |
| 03/14/2002 | US20020032915 Detecting size defect in animal infants; obtain tissue biopsy, monitor expression of somatomedins in sample, amplified somatomedin concentration indicates potential size defect in animals |
| 03/14/2002 | US20020032329 Method for the preparation of tetrahydrobenzothiepines |
| 03/14/2002 | US20020032234 First fatty acid compound that is a linoleic or linolenic compound and a second fatty acid that is a docosahexaenoic acid compound, an omega-3 or an omega-2 fatty acid or derivative |
| 03/14/2002 | US20020032229 Novel compounds having antitumor activity: process for their preparation and pharmaceutical compositions containing them |
| 03/14/2002 | US20020032225 Treatment of inflammation, inflammatory and immunological diseases, insulin resistance, hyperlipidemia, coronary artery disease, cancer and multiple sclerosis. |
| 03/14/2002 | US20020032222 Azolidines as beta-3 adrenergic receptor agonists |
| 03/14/2002 | US20020032218 Substituted stilbenes as glucose uptake enhancers |
| 03/14/2002 | US20020032204 Reacting a substituted indol-2-one compound with an acyclic or cyclic amine free of piperidine-1-yl or morpholine-4-yl to form protein kinase inhibitor |
| 03/14/2002 | US20020032197 Methods and compositions for using moclobemide |
| 03/14/2002 | US20020032196 CRF receptor antagonists and methods relating thereto |
| 03/14/2002 | US20020032194 CRF receptor antagonists and methods relating thereto |
| 03/14/2002 | US20020032191 6-phenylpyridyl-2-amine derivatives useful as NOS inhibitors |
| 03/14/2002 | US20020032181 For therapy of conditions or diseases that are estrogen-dependent, i.e., are estrogen-induced or estrogen-stimulated |
| 03/14/2002 | US20020032157 Methods of inhibiting ectopic calcification |
| 03/14/2002 | US20020031797 Novel nucleic acid isolated from tetrahymena which codes for a triterpenoid cyclase, its production, and use |
| 03/14/2002 | US20020031759 Diagnosing pancreatic defect in humans; obtain organelle sample, detect preferential organelle, monitor sample for organelle defect, diagnose pancreatic defect |
| 03/14/2002 | US20020031554 Asthma therapy; dietetic nutrient |
| 03/14/2002 | US20020031529 Neurotoxin therapy for diabetes |
| 03/14/2002 | US20020031517 Administering an inhibitor of GDF-8, or a related member of Transforming Growth Factor-beta superfamily of structurally-related growth factors |
| 03/14/2002 | US20020031507 Treatment of inflammatory processes of the intestine, hypercholesterolaemia and infections with Helicobacter pylori; anticarcinogenic agent |
| 03/14/2002 | DE10043227A1 Neuartiges entwicklungsbiologisches Gen Novel biological developmental gene |